AAAAAA

   
Results: 1-25 | 26-50 | 51-56 |
Results: 51-56/56

Authors: Abbamonte, P Burns, CA Isaacs, ED Platzman, PM Miller, LL Cheong, SW Klein, MV
Citation: P. Abbamonte et al., Resonant inelastic x-ray scattering from valence excitations in insulatingcopper oxides, PHYS REV L, 83(4), 1999, pp. 860-863

Authors: Rothenberg, ML Cox, JV DeVore, RF Hainworth, JD Pazdur, R Rivkin, SE Macdonald, JS Geyer, CE Sandbach, J Wolf, SL Mohrland, JS Elfring, GL Miller, LL Von Hoff, DD
Citation: Ml. Rothenberg et al., A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma, CANCER, 85(4), 1999, pp. 786-795

Authors: Miller, LL Korn, EL Stevens, DS Janik, JE Gause, BL Kopp, WC Holmlund, JT Curti, BD Sznol, M Smith, JW Urba, WJ Donegan, SE Watson, TM Longo, DL
Citation: Ll. Miller et al., Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin, BLOOD, 93(10), 1999, pp. 3250-3258

Authors: Miller, LL
Citation: Ll. Miller, Marihuana - Acute effects on human memory, MARIHUANA AND MEDICINE, 1999, pp. 227-231

Authors: Saltz, LB Spriggs, D Schaaf, LJ Schwartz, GK Ilson, D Kemeny, N Kanowitz, J Steger, C Eng, M Albanese, P Semple, D Hanover, CK Elfring, GL Miller, LL Kelsen, D
Citation: Lb. Saltz et al., Phase I clinical and pharmacologic study of weekly cisplatin combined withweekly irinotecan in patients with advanced solid tumors, J CL ONCOL, 16(12), 1998, pp. 3858-3865

Authors: Ronning, F Kim, C Feng, DL Marshall, DS Loeser, AG Miller, LL Eckstein, JN Bozovic, I Shen, ZX
Citation: F. Ronning et al., Photoemission evidence for a remnant fermi surface and a d-wave-like dispersion in insulating Ca2CuO2Cl2, SCIENCE, 282(5396), 1998, pp. 2067-2072
Risultati: 1-25 | 26-50 | 51-56 |